Keynote speaker
Medical Director, Global Clinical Development, Late Stage Cardiovascular, Renal & Metabolism, AstraZeneca
Alok Pachori, Medical Director, Global Clinical Development, Late Stage Cardiovascular, Renal & Metabolism at AstraZeneca, gave a keynote at 10th MASH Drug Development Summit 2026 (Boston, United States of America, 15–17 Sept 2026) in the session “Advancing Genetically Validated Targets & Combination Development Strategies to Improve Therapeutic Precision, Enable Differentiation & Support Long-Term Success in MASH”.
15–17 Sept 2026Boston, United States of America
Director, Madrigal Pharmaceuticals
Senior Director, Cellarity
Chief Executive Officer, Cirius Therapeutics
Faculty, Harvard Medical School and Mass General Brigham
Associate Director, Clinical Research, Akero Therapeutics
Vice President, Discovery Biology, Sepia Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Alok Pachori, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].